VC-backed Corium files for IPO
Corium International has filed for an IPO. The number of shares that will be sold as well as the price range of the offering have yet to be set. Corium will trade its stock on the NASDAQ under the ticker symbol "CORI." Jefferies and Leerink Partners will serve as lead underwriters. Based in Menlo Park, Calif., Corium is a developer of advanced transdermal drug delivery technologies and products. It is backed by Essex Woodlands Health Ventures, Quantum Technology Partners and Aphelion Capital.
4 March 2014•2 mins read
